Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses

Microbial Pathogenesis
Jae Su NhoJe Chul Lee

Abstract

Acinetobacter nosocomialis is an important nosocomial pathogen that causes a variety of opportunistic infections; however, pathogenesis of this microorganism has not yet been characterized. The aim of this study was to investigate the secretion of outer membrane vesicles (OMVs) from A. nosocomialis and to determine their cytotoxic effects and their ability to induce inflammatory responses both in vitro and in vivo by using human epithelial HEp-2 cells and a mouse model, respectively. A. nosocomialis ATCC 17903(T) secreted spherical OMVs when cultured in vitro. Proteomic analysis revealed that 147 different proteins were associated with A. nosocomialis OMVs and virulence-associated proteins, such as outer membrane protein A (OmpA), CsuA, CsuC, CsuD, PilW, hemolysin, and serine protease, were identified. A. nosocomialis OMVs were cytotoxic to HEp-2 cells. These vesicles also induced the expression of pro-inflammatory cytokine genes in the HEp-2 cells. Early inflammatory responses, such as congestion and focal neutrophilic infiltration, were observed in the lungs of mice injected with A. nosocomialis OMVs. In conclusion, A. nosocomialis OMVs are important secretory nanocomplexes that induce cytotoxicity of epithelial cells and hos...Continue Reading

References

Feb 12, 1998·The Journal of Infection·C H YangC K Wang
Dec 6, 2005·Research in Microbiology·Je Chul LeeLenie Dijkshoorn
Nov 17, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H-W LeeJ Kim
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter J SebenyKyle Petersen
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Jun 25, 2009·FEMS Microbiology Letters·Sang-Oh KwonSeung Il Kim
Mar 4, 2010·Microbiology and Molecular Biology Reviews : MMBR·Terri N Ellis, Meta J Kuehn
Sep 10, 2010·Annual Review of Microbiology·Adam Kulp, Meta J Kuehn
Jan 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yu-Chung ChuangShan-Chwen Chang
Jun 21, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Hau-Shin WuChang-Phone Fung
Oct 5, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·X SchleicherH Seifert
Mar 23, 2013·Research in Microbiology·Roman I KoningLenie Dijkshoorn
May 14, 2014·Antimicrobial Agents and Chemotherapy·Sarunyou ChusriYohei Doi

❮ Previous
Next ❯

Citations

Aug 3, 2016·Proteomics. Clinical Applications·Jaewook LeeYong Song Gho
Dec 30, 2015·Journal of Bacteriology·Brent S WeberMario F Feldman
Dec 16, 2016·Clinical Microbiology Reviews·Darren WongBrad Spellberg
Apr 2, 2021·Frontiers in Cellular and Infection Microbiology·Indranil Chattopadhyay, Esaki M Shankar
May 1, 2021·International Journal of Molecular Sciences·Felix BehrensSzandor Simmons
Oct 13, 2021·The EMBO Journal·Hannah M McMillan, Meta J Kuehn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.